Skip to main content
. 2022 Dec 30;22(9):2217–2227. doi: 10.1111/ajt.17126

TABLE 2.

Organ disposition of donors by SARS-CoV-2 status

Organ (row %)a SARS-CoV-2 status Not recovered Recovered for transplant but not transplanted Transplanted Total (n)
Right kidney Final test positive (F-POS) 2 (2.9%) 26 (37.7%)b 41 (59.4%) 69
Previously positive (P-POS)c 8 (4.0%) 55 (27.6%)b 136 (68.3%) 199
All test(s) negative 715 (4.5%) 3345 (21.1%)b 11 797 (74.4%) 15 867
Left kidney Final test positive (F-POS) 3 (4.4%) 21 (30.4%)b 45 (65.2%) 69
Previously positive (P-POS)c 8 (4.0%) 50 (25.1%)b 141 (70.9%) 199
All test(s) negative 727 (4.5%) 3139 (19.8%)b 11 992 (75.6%) 15 858
Liver Final test positive (F-POS) 33 (47.8%) 4 (5.8%) 32 (46.4%) 69
Previously positive (P-POS)c 70 (36.1%) 8 (4.1%) 116 (59.8%) 194
All test(s) negative 3816 (24.4%)c 1121 (7.2%) 10 678 (68.4%) 15 615
Heart Final test positive (F-POS) 60 (87.0%) 0 (0%) 9 (13.0%) 69
Previously positive (P-POS)c 136 (72.0%) 0 (0%) 53 (28.0%) 189
All test(s) negative 9209 (65.3%)c 47 (0.3%) 4857 (34.4%) 14 113

Abbreviation: SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

a

Sample size for other organs (lung, pancreas, liver segment, intestine, en-bloc kidneys) all <10 for positive SARS-CoV-2 status and excluded from table; dispositions of no authorization requested or obtained and recovered not for transplant excluded from analysis.

b

p-value <.05 for association of recovery or discard with SARS-CoV-2 status.

c

P-POS—former positive SARS-CoV-2 test, but final test negative.